Mutual Advisors LLC Grows Position in The Clorox Company $CLX

Mutual Advisors LLC increased its position in shares of The Clorox Company (NYSE:CLX) by 63.4% during the second quarter, Holdings Channel reports. The institutional investor owned 2,634 shares of the company’s stock after buying an additional 1,022 shares during the quarter. Mutual Advisors LLC’s holdings in Clorox were worth $345,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of Clorox by 0.6% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company’s stock worth $1,953,000 after buying an additional 73 shares during the period. Horizon Investments LLC boosted its holdings in Clorox by 4.4% in the first quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock valued at $258,000 after purchasing an additional 75 shares in the last quarter. Sfmg LLC boosted its holdings in Clorox by 2.8% in the first quarter. Sfmg LLC now owns 2,780 shares of the company’s stock valued at $409,000 after purchasing an additional 76 shares in the last quarter. Hancock Whitney Corp boosted its holdings in Clorox by 4.3% in the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after purchasing an additional 86 shares in the last quarter. Finally, Brown Lisle Cummings Inc. boosted its holdings in Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is owned by company insiders.

Clorox Price Performance

CLX stock opened at $119.60 on Tuesday. The company has a market capitalization of $14.56 billion, a P/E ratio of 18.34, a PEG ratio of 0.99 and a beta of 0.52. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The business has a 50 day simple moving average of $121.56 and a 200-day simple moving average of $127.42. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Wells Fargo & Company lowered their price target on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. The Goldman Sachs Group lowered their price target on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. UBS Group lowered their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Finally, Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $130.20.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.